Exact(2)
With alum as sole adjuvant, NIC7-CRM wasuperioror to NIC-VLP for Ab titer, avidity and ex vivo function (83% and 27% nicotine binding at 40 ng/mL respectively), but equivalent for in vivo function after intravenous [IV] nicotine challenge (brain levels reduced ~ 10%).
Although governments and private organizations have tried to address this policy challenge, brain drain continues to destabilise public health systems and their populations globally.
Similar(58)
SECOND SUNDAY PUZZLE — It's always tough to come up with things to say about the Diagramless puzzles, not because they are not challenging brain twisters and not because they are not fun to solve — they most definitely are — but because anything that I say about them is likely to be fairly obvious.
The barrier of aglycemia challenged brain endothelial at 4d was 78.74 ± 2.3%.
No significant differences were observed between normal and aglycemia challenged brain endothelial barrier until 3d.
At 4d the barrier of hypoxia challenged brain endothelial was 63.7 ± 0.9%.
Both OGDR challenged neurovasculature and gliovasculature significantly promoted lymphocyte adhesion compared to OGDR challenged brain endothelial cells in vitro.
However, both aglycemia challenged neurons and astrocytes significantly induced E-selectin expression compared to aglycemia challenged brain endothelial cells.
CM from aglycemia challenged neurons significantly decreased MAdCAM-1 expression compared to aglycemia challenged brain endothelial CM.
Hypoxia challenged brain endothelial barrier showed a progressive loss of barrier from 1d similar to normal brain endothelial barrier.
Similar to aglycemia, OGDR challenged brain endothelial, neurovascular and gliovascular barriers showed differential responses in a time dependent manner.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com